GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/25/2026 8:35:31 AM | View | Financials | Earnings | SEC | 3Q 2026 | Export Earnings Model | ||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/11/2026 7:04:23 AM | View | Proxy | SEC | Y 2025 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 7/30/2026 8:17:13 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $1,061,000 -12.3% | Assets $128,766,000 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/9/2026 4:55:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 12/31/2025 | Rev: $1,079,000 -22.6% | Assets $132,989,000 | EPS -$0.06 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/9/2026 7:32:54 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $1,079,000 -22.6% | Assets $132,989,000 | EPS -$0.06 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 11/25/2025 4:43:58 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 9/30/2025 | Rev: $4,678,000 -36.1% | Assets $103,815,000 | EPS -$0.54 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 11/25/2025 7:32:00 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $999,000 -43.2% | Assets $103,815,000 | EPS -$0.11 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/12/2025 4:14:11 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 6/30/2025 | Rev: $1,075,000 -40.1% | Assets $102,432,000 | EPS -$0.16 | |
| Anavex Life Sciences Corp. (AVXL) | 8/12/2025 7:30:26 AM | View | Financials | Earnings | WIRE | 3Q 2025 | Rev $1,075,000 -40.1% | Assets $102,432,000 | EPS -$0.16 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/13/2025 4:44:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 3/31/2025 | Rev: $1,210,000 -31.1% | Assets $117,139,000 | EPS -$0.13 | |
| Anavex Life Sciences Corp. (AVXL) | 5/13/2025 7:31:40 AM | View | Financials | Earnings | WIRE | 2Q 2025 | Rev $1,210,000 -31.1% | Assets $117,139,000 | EPS -$0.13 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 4/25/2025 4:43:41 PM | View | Proxy | SEC | Y 2024 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/12/2025 9:12:47 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 12/31/2024 | Rev: $1,394,000 -30.6% | Assets $124,043,000 | EPS -$0.14 | |
| Anavex Life Sciences Corp. (AVXL) | 2/12/2025 7:31:03 AM | View | Financials | Earnings | WIRE | 1Q 2025 | Rev $1,394,000 -30.6% | Assets $124,043,000 | EPS -$0.14 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/23/2024 4:45:09 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 9/30/2024 | Rev: $7,320,000 +12.3% | Assets $135,567,000 | EPS -$0.52 | |
| Anavex Life Sciences Corp. (AVXL) | 12/23/2024 7:32:12 AM | View | Financials | Earnings | WIRE | Y 2024 | Rev $1,759,000 -10.2% | Assets $135,567,000 | EPS -$0.14 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/6/2024 5:35:43 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 6/30/2024 | Rev: $1,796,000 -1.7% | Assets $141,535,000 | EPS -$0.14 | |
| Anavex Life Sciences Corp. (AVXL) | 8/6/2024 7:32:17 AM | View | Financials | Earnings | WIRE | 3Q 2024 | Rev $1,796,000 -1.7% | Assets $141,535,000 | EPS -$0.14 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/9/2024 4:47:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 3/31/2024 | Rev: $1,756,000 +19.8% | Assets $144,516,000 | EPS -$0.13 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/9/2024 8:01:19 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $1,756,000 +19.8% | Assets $144,516,000 | EPS -$0.13 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/6/2024 8:25:02 AM | View | Proxy | SEC | Y 2023 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/7/2024 4:49:53 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 12/31/2023 | Rev: $2,008,000 +58.4% | Assets $148,070,000 | EPS -$0.11 | |
| Anavex Life Sciences Corp. (AVXL) | 2/7/2024 7:31:43 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Rev $2,008,000 +58.4% | Assets $148,070,000 | EPS -$0.11 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 11/27/2023 4:45:42 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 9/30/2023 | Rev: $6,519,000 +588.4% | Assets $154,386,000 | EPS -$0.60 | |
| Anavex Life Sciences Corp. (AVXL) | 11/27/2023 8:02:29 AM | View | Financials | Earnings | WIRE | Y 2023 | Rev $1,958,216 +177.9% | Assets $154,386,000 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/8/2023 4:47:18 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 6/30/2023 | Rev: $1,827,945 +695.0% | Assets $157,809,863 | ||
| Anavex Life Sciences Corp. (AVXL) | 8/8/2023 7:33:48 AM | View | Financials | Earnings | WIRE | 3Q 2023 | Rev $1,827,945 +695.0% | Assets $157,809,863 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/9/2023 4:45:08 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 3/31/2023 | Rev: $1,465,221 +19,235.2% | Assets $159,186,397 | ||
| Anavex Life Sciences Corp. (AVXL) | 5/9/2023 7:32:40 AM | View | Financials | Earnings | WIRE | 2Q 2023 | Rev $1,465,221 +19,235.2% | Assets $159,186,397 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 4/4/2023 4:34:50 PM | View | Proxy | SEC | Y 2022 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/7/2023 5:28:31 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 12/31/2022 | Rev: $1,267,618 +25,717.1% | Assets $148,371,922 | ||
| Anavex Life Sciences Corp. (AVXL) | 2/7/2023 7:17:59 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Rev $1,267,618 +25,717.1% | Assets $148,371,922 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 11/28/2022 5:18:34 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 9/30/2022 | Rev: $946,988 +3,506.1% | Assets $152,704,603 | ||
| Anavex Life Sciences Corp. (AVXL) | 11/28/2022 7:02:12 AM | View | Financials | Earnings | WIRE | Y 2022 | Rev $704,583 +9,752.9% | Assets $152,704,603 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/11/2022 4:06:25 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 6/30/2022 | Rev: $229,917 +1,907.5% | Assets $160,221,144 | ||
| Anavex Life Sciences Corp. (AVXL) | 8/9/2022 7:02:34 AM | View | Financials | Earnings | WIRE | 3Q 2022 | Rev $229,917 +1,907.5% | Assets $160,221,144 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/10/2022 4:49:29 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 3/31/2022 | Rev: $7,578 -17.8% | Assets $160,276,148 | ||
| Anavex Life Sciences Corp. (AVXL) | 5/10/2022 7:02:27 AM | View | Financials | Earnings | WIRE | 2Q 2022 | Rev $7,578 -17.8% | Assets $160,276,148 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 4/11/2022 5:10:03 PM | View | Proxy | SEC | Y 2021 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/9/2022 4:45:17 PM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 12/31/2021 | Rev: $4,910 | Assets $156,896,368 | ||
| Anavex Life Sciences Corp. (AVXL) | 2/9/2022 7:29:15 AM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $4,910 | Assets $156,896,368 | Export Earnings Model | ||
| Anavex Life Sciences Corp. (AVXL) | 11/24/2021 5:25:13 PM | View | Financials | Earnings | WIRE | Y 2021 | Rev $7,151 +2.5% | Assets $161,616,490 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 11/24/2021 4:40:45 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 9/30/2021 | Rev: $26,261 -85.4% | Assets $161,616,490 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/12/2021 5:21:22 PM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 6/30/2021 | Rev: $11,453 -79.6% | Assets $166,419,501 | ||
| Anavex Life Sciences Corp. (AVXL) | 8/12/2021 7:02:05 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Rev $11,453 -79.6% | Assets $166,419,501 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/13/2021 4:46:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 3/31/2021 | Rev: $9,216 -86.9% | Assets $83,574,238 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 4/12/2021 4:07:26 PM | View | Proxy | SEC | Y 2020 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/16/2021 5:31:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 12/31/2020 | Assets $54,334,246 | EPS -$0.12 | ||
| Anavex Life Sciences Corp. (AVXL) | 2/11/2021 7:16:18 AM | View | Financials | Earnings | WIRE | 1Q 2021 | Rev ($1,559) | Assets $54,334,246 | EPS -$0.12 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/28/2020 5:32:43 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 9/30/2020 | Rev: $179,973 -13.2% | Assets $34,542,197 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/28/2020 5:30:24 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $6,977 -83.5% | Assets $34,542,197 | Export Earnings Model | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/6/2020 4:31:20 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 6/30/2020 | Rev: $56,096 +61.0% | Assets $31,630,256 | EPS -$0.11 | |
| Anavex Life Sciences Corp. (AVXL) | 8/6/2020 7:11:08 AM | View | Financials | Earnings | WIRE | 3Q 2020 | Rev $56,096 +61.0% | Assets $31,630,256 | EPS -$0.11 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/7/2020 4:46:53 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 3/31/2020 | Rev: $70,180 +36.4% | Assets $31,020,577 | EPS -$0.12 | |
| Anavex Life Sciences Corp. (AVXL) | 5/7/2020 7:01:48 AM | View | Financials | Earnings | WIRE | 2Q 2020 | Rev $70,180 +36.4% | Assets $31,020,577 | EPS -$0.12 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/20/2020 4:32:44 PM | View | Proxy | SEC | Y 2019 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/6/2020 6:58:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 12/31/2019 | Rev: $46,720 -40.7% | Assets $31,424,067 | EPS -$0.12 | |
| Anavex Life Sciences Corp. (AVXL) | 2/6/2020 7:01:41 AM | View | Financials | Earnings | WIRE | 1Q 2020 | Rev $46,720 -40.7% | Assets $31,424,067 | EPS -$0.12 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/16/2019 5:41:17 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 9/30/2019 | Rev: $207,280 -18.7% | Assets $25,329,373 | EPS -$0.54 | |
| Anavex Life Sciences Corp. (AVXL) | 12/16/2019 7:01:25 AM | View | Financials | Earnings | WIRE | Y 2019 | Rev $42,177 -49.7% | Assets $25,329,373 | EPS -$0.11 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/7/2019 4:16:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 6/30/2019 | Rev: $34,838 -69.0% | Assets $21,968,271 | EPS -$0.13 | |
| Anavex Life Sciences Corp. (AVXL) | 8/7/2019 7:01:53 AM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $34,838 -69.0% | Assets $21,968,271 | EPS -$0.13 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/9/2019 6:26:05 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 3/31/2019 | Rev: $51,465 +79.7% | Assets $20,549,780 | EPS -$0.15 | |
| Anavex Life Sciences Corp. (AVXL) | 5/8/2019 7:01:56 AM | View | Financials | Earnings | WIRE | 2Q 2019 | Rev $51,465 +79.7% | Assets $20,549,780 | EPS -$0.15 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/11/2019 4:12:46 PM | View | Proxy | SEC | Y 2018 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/7/2019 5:10:45 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 12/31/2018 | Rev: $78,800 +159.4% | Assets $22,095,679 | EPS -$0.15 | |
| Anavex Life Sciences Corp. (AVXL) | 2/7/2019 7:01:41 AM | View | Financials | Earnings | WIRE | 1Q 2019 | Rev $78,800 +159.4% | Assets $22,095,679 | EPS -$0.15 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 1/25/2019 5:12:42 PM | Micro | View | Financials | 10-K/A | SEC | Y 2018 ending: 9/30/2018 | Rev: $255,092 +189.6% | Assets $26,206,322 | EPS -$0.39 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/13/2018 8:41:58 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 9/30/2018 | Rev: $255,092 +189.6% | Assets $26,206,322 | EPS -$0.39 | |
| Anavex Life Sciences Corp. (AVXL) | 12/12/2018 7:02:28 AM | View | Financials | Earnings | WIRE | Y 2018 | Rev $83,843 +111.6% | Assets $26,206,322 | EPS -$0.13 | Export Earnings Model | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/9/2018 5:06:37 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 6/30/2018 | Rev: $112,226 +320.7% | Assets $26,794,693 | EPS -$0.06 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/10/2018 5:25:23 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 3/31/2018 | Rev: $28,647 +57.9% | Assets $25,895,594 | EPS -$0.11 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 3/8/2018 6:08:56 AM | View | Proxy | SEC | Y 2017 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/7/2018 5:14:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 12/31/2017 | Rev: $30,376 +731.1% | Assets $28,343,807 | EPS -$0.09 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/11/2017 5:22:23 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 9/30/2017 | Rev: $88,098 +678.1% | Assets $27,838,329 | EPS -$0.33 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/7/2017 4:43:43 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 6/30/2017 | Rev: $26,677 +915.9% | Assets $24,906,730 | EPS -$0.04 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/10/2017 4:33:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 3/31/2017 | Rev: $18,147 +779.2% | Assets $23,606,588 | EPS -$0.04 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 3/10/2017 7:14:23 AM | View | Proxy | SEC | Y 2016 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/7/2017 4:31:25 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 12/31/2016 | Rev: $3,655 +70.6% | Assets $21,373,982 | EPS -$0.08 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/14/2016 4:06:55 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 9/30/2016 | Rev: $11,322 | Assets $9,498,681 | EPS -$0.42 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/11/2016 4:33:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 6/30/2016 | Rev: $2,626 +109.4% | Assets $9,843,973 | EPS -$0.06 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/11/2016 4:38:49 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 3/31/2016 | Rev: $2,064 | Assets $12,115,249 | EPS -$0.06 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 4/1/2016 4:54:31 PM | View | Proxy | SEC | Y 2015 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/8/2016 11:25:34 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 12/31/2015 | Rev: $2,142 | Assets $14,023,960 | EPS -$0.12 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/29/2015 8:11:09 AM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 9/30/2015 | Assets $15,469,913 | EPS -$0.65 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/14/2015 4:10:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 6/30/2015 | Rev: $1,254 | Assets $7,978,886 | EPS -$0.22 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/14/2015 4:51:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 3/31/2015 | Assets $6,364,377 | EPS -$0.12 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/17/2015 3:28:34 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 12/31/2014 | Assets $7,050,498 | EPS -$0.06 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/13/2015 10:09:11 AM | View | Proxy | SEC | Y 2014 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/29/2014 4:02:05 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 9/30/2014 | Assets $7,353,502 | EPS -$1.02 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/13/2014 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 6/30/2014 | Assets $9,313,916 | EPS -$0.03 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/30/2014 5:30:00 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2014 ending: 3/31/2014 | Assets $10,292,520 | EPS -$0.03 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/14/2014 2:44:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 12/31/2013 | Assets $150,887 | EPS -$0.01 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/30/2013 2:23:57 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 9/30/2013 | Assets $393,449 | EPS -$0.12 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/14/2013 5:48:08 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 6/30/2013 | Assets $3,480 | EPS -$0.01 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/17/2013 4:11:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 3/31/2013 | Assets $487 | |||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/14/2013 4:18:53 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 12/31/2012 | Assets $79,900 | EPS -$0.01 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/31/2012 3:07:09 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 9/30/2012 | Assets $13,153 | EPS -$0.29 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/17/2012 4:59:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 6/30/2012 | Assets $22,135 | EPS -$0.16 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 5/15/2012 4:05:40 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 3/31/2012 | Assets $191,100 | EPS -$0.03 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/14/2012 2:45:55 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 12/31/2011 | Assets $84,593 | EPS -$0.08 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 12/22/2011 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 9/30/2011 | Assets $203,039 | EPS -$0.29 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 8/12/2011 4:08:52 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 6/30/2011 | Assets $1,279,234 | EPS -$0.06 | ||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 3/4/2011 2:23:40 PM | View | Proxy | SEC | Y 2010 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 4/1/2010 2:53:09 PM | View | Proxy | SEC | Y 2009 | ||||||
| ANAVEX LIFE SCIENCES CORP. (AVXL) | 2/27/2009 5:18:39 PM | View | Proxy | SEC | Y 2008 |